Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

200720062004

Nov 9, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that the company will present at the Jefferies London Healthcare Conference on November 15, 2017 at 12:40 p.m. (GMT). A webcast of the...

More
Nov 6, 2017

Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2018 first quarter ended September 30, 2017. "In recent weeks, we announced a number of very positive developments...

More
Nov 1, 2017

Lannett Company, Inc. (NYSE: LCI) today responded to the allegations in the amended civil complaint by a number of states' attorneys general pending in the U.S. District Court for the Eastern...

More
Oct 30, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S....

More
Oct 26, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2018 first quarter on Monday, November 6, 2017, after the market closes. Lannett management...

More
Oct 2, 2017
--Company Cleared to Market Prescription and OTC Generic Prevacid®--

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Lansoprazole...

More
Sep 27, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone and...

More
Sep 26, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dexmethylphenidate...

More
Sep 26, 2017

Lannett Company, Inc. (NYSE: LCI) today announced that the United States District Judge for the Eastern District of Pennsylvania dismissed in its entirety a putative class action lawsuit against a...

More
Sep 25, 2017
--CEO Arthur Bedrosian to Step Down Upon Naming of a Successor--

Lannett Company, Inc. (NYSE: LCI) today announced that its board of directors has begun a search for a new chief executive officer (CEO). As part of the unanimously approved search process, the...

More
 

print email rss
Lannett Investor Relations
Lannett Company Products